Compare TLSI & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSI | SGC |
|---|---|---|
| Founded | 2010 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.0M | 214.8M |
| IPO Year | 2020 | 1994 |
| Metric | TLSI | SGC |
|---|---|---|
| Price | $2.42 | $13.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $10.00 | ★ $18.67 |
| AVG Volume (30 Days) | ★ 192.8K | 28.8K |
| Earning Date | 11-10-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.31 |
| Revenue | $45,151,000.00 | ★ $566,184,000.00 |
| Revenue This Year | $14.10 | $3.00 |
| Revenue Next Year | $37.87 | $5.29 |
| P/E Ratio | ★ N/A | $43.89 |
| Revenue Growth | ★ 53.41 | 0.09 |
| 52 Week Low | $2.20 | $8.30 |
| 52 Week High | $7.95 | $14.70 |
| Indicator | TLSI | SGC |
|---|---|---|
| Relative Strength Index (RSI) | 23.71 | 56.60 |
| Support Level | $2.20 | $11.74 |
| Resistance Level | $4.35 | $14.57 |
| Average True Range (ATR) | 0.31 | 0.78 |
| MACD | -0.09 | 0.05 |
| Stochastic Oscillator | 6.72 | 58.97 |
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.